Expression of Biologically Active Isoforms of the Tumor Angiogenesis Factor VEGF inEscherichia coli

1996 ◽  
Vol 222 (2) ◽  
pp. 249-255 ◽  
Author(s):  
Gerhard Siemeister ◽  
Bernhard Schnurr ◽  
Katja Mohrs ◽  
Christoph Schächtele ◽  
Dieter Marmé ◽  
...  
1982 ◽  
Vol 10 (16) ◽  
pp. 4883-4890 ◽  
Author(s):  
Maria L. Gennaro ◽  
Peter J. Greenaway ◽  
David A. Broadbent

Urology ◽  
1986 ◽  
Vol 27 (5) ◽  
pp. 447-450 ◽  
Author(s):  
Richard H. Bard ◽  
Jack H. Mydlo ◽  
Selwyn Z. Freed

1998 ◽  
Vol 12 (2) ◽  
pp. 249-258 ◽  
Author(s):  
Yves Guisez ◽  
Ina Faché ◽  
L.Arthur Campfield ◽  
Françoise J. Smith ◽  
Adrienne Farid ◽  
...  

1971 ◽  
Vol 133 (2) ◽  
pp. 275-288 ◽  
Author(s):  
Judah Folkman ◽  
Ezio Merler ◽  
Charles Abernathy ◽  
Gretchen Williams

Human and animal solid tumors elaborate a factor which is mitogenic to capillary endothelial cells. This factor has been called tumor-angiogenesis factor. The important components of TAF are RNA and protein. It is suggested that blockade of this factor (inhibition of angiogenesis) might arrest solid tumors at a tiny diameter of a few millimeters.


1992 ◽  
Vol 56 (12) ◽  
pp. 1985-1990 ◽  
Author(s):  
Kiyoshi Fujimori ◽  
Shinichi Fukuzono ◽  
Naoe Kotomura ◽  
Norihito Kuno ◽  
Norio Shimizu

2016 ◽  
Vol 76 (7) ◽  
pp. 1673-1674 ◽  
Author(s):  
Rebecca G. Bagley

1996 ◽  
Vol 325 (1) ◽  
pp. 8-19 ◽  
Author(s):  
James A. Bassuk ◽  
François Baneyx ◽  
Robert B. Vernon ◽  
Sarah E. Funk ◽  
E.Helene Sage

Sign in / Sign up

Export Citation Format

Share Document